溶解性 | DMSO ≥200mg/mL Water ≥1.2mg/mL Ethanol ≥200mg/mL |
存贮条件 | 储存温度-20°C |
应用 | A potent inhibitor of FRAP (mTOR) kinase activity |
产品介绍 | Temsirolimus (CCI-779) 抑制mTOR激酶活性 IC50值为1.76 ± 0.15 μM。 |
备注 | Temsirolimus (CCI-779) is a specific mTOR inhibitor with IC50 of 1.76 μM. |
生化机理 | Temsirolimus (also known as CCI-779) is a recently developed mTOR inhibitor. with improved aqueous solubility and more favorable pharmaceutical properties compared with the parent compound rapamycin. |
别名 | 西罗莫司脂化物; 雷帕霉素 42-[3-羟基-2-(羟甲基)-2-甲基丙酸酯;Torisel;CCI-779;CCI 779;CCI779;Rapamycin 42-(2,2-bis(hydroxymethyl)propionate);Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate |
替西罗莫司
Temsirolimus (CCI-779, NSC 683864) (订货以英文为准)
编号:T126606
CAS号:162635-04-3
分子式:C56H87NO16
分子量:1030.29
产品名称 | Temsirolimus (CCI-779, NSC 683864) |
中文名称 | 替西罗莫司 |
CAS号 | 162635-04-3 |
分子式(M.F.) | C56H87NO16 |
分子量(M.W.) | 1030.29 |
储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品